AEHR Stock Surges As Traders Pile Into AI And EV Test Play

Aehr Test Systems soared as a major new silicon carbide test contract drove optimism; stocks have been trading up by 25.43 percent.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading AEHR

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Fiscal Q4 revenue jumped 33% year over year to about $18.8M, with AEHR swinging from a loss to GAAP and non-GAAP profitability on adjusted EPS of $0.11 versus expectations for a loss.
Management now guides fiscal 2027 revenue to $130–$150M, roughly 160%–200% growth versus about $85M Street consensus, backed by an effective backlog near $100M and demand in AI and power semis.
Record Q4 bookings of $60.7M lifted effective backlog to about $100.6M, while cash reached $116.5M after an equity raise, giving AEHR firepower to support growth.
The stock ripped roughly 27%–31% on heavy volume after earnings, trading intraday around $91.20 and signaling a sharp positive re-rating by the market.
Street sentiment flipped aggressively bullish, with Lake Street doubling its price target to $110, Craig-Hallum hiking to $125, and Freedom Broker upgrading to Buy with a $110 target.

Quick Financial Overview

Aehr Test Systems just delivered the kind of quarter that resets a chart. Fiscal Q4 revenue came in around $18.8M, up 33% year over year and a touch ahead of expectations. More important for traders, AEHR moved from a loss last year to a $0.11 adjusted EPS profit, beating forecasts that were still looking for red ink.

Under the hood, the fundamentals show a classic high‑growth, high‑expectation profile. AEHR runs at a roughly 30.7% gross margin but has been reinvesting heavily, which is why trailing operating margins were negative until this inflection. Revenue over the past three years dipped, yet the five‑year trend is still strong, and management is now leaning into what it sees as a new demand wave in AI processors, silicon photonics, and power semis.

More Breaking News

On the balance sheet, AEHR is light on debt with total debt-to-equity near 0.07 and a current ratio around 11. That is a lot of liquidity for a company with about $58.97M in annual revenue. The flip side is valuation: a price-to-sales ratio near 59 and price-to-book around 19 tell traders they are paying up for growth and momentum. The recent move from roughly $69–$72 to $97 in a few sessions shows how quickly sentiment can swing in a name like AEHR.

Why Traders Are Watching AEHR Now

AEHR has turned into a live-wire momentum story after earnings. The catalyst was a clean combo: a swing to profit, an earnings beat, and guidance that blasted past what the Street was modeling. Management now expects fiscal 2027 revenue between $130M and $150M, implying 160%–200% growth off current levels and far above the roughly $85M consensus. For a small-cap test equipment name, that is not a tweak; it is a whole new playbook.

Backing that guidance, Aehr Test Systems reported record Q4 bookings of $60.7M and an effective backlog of about $100.6M, plus $116.5M in cash after an equity raise. Traders love when big promises are tethered to actual orders and cash in the bank, not just slideware. That is what is happening with AEHR.

On the demand side, the story hits every hot theme on a momentum trader’s screen. AEHR is winning over $8M in new silicon carbide wafer-level burn-in orders tied to expanding EV programs in China and a qualification order from one of the world’s top automakers. At the same time, it landed a follow-on FOX-XP system order from its lead silicon photonics customer, aimed at high-volume AI optical interconnects for hyperscale data centers. Put bluntly, AEHR sits at the test stage of two secular buildouts: EV power semis and AI data center infrastructure.

The market noticed. After the Q4 print and outlook, AEHR shares surged roughly 27%–31% on heavy volume, with one report pegging an intraday jump of 26.6% to around $91.20. That type of rip, off a base in the high $60s to low $70s days earlier, drags in breakout traders, short-covering, and late chasers. The daily chart now shows a powerful push from $72.01 on 2026/07/14 to $97.01 on 2026/07/21, with intraday action around $97 holding firm. The five‑minute tape shows steady higher lows through the morning and tight consolidation near $97 midday — classic post‑gap digestion rather than immediate failure.

Wall Street is chasing too. Lake Street doubled its AEHR price target to $110. Craig-Hallum raised from $68 to $125, expecting revenue to nearly triple by 2027 on AI and silicon photonics demand. Freedom Broker upgraded Aehr Test Systems to Buy and bumped its target to $110 after calling this quarter a long-awaited growth inflection and lifting its FY27 and FY30 forecasts. For traders, that kind of across-the-board reset often fuels secondary legs in a trend — but it also means expectations are now stacked high.

Conclusion

AEHR has morphed from a niche test-equipment story into a pure-play on some of the market’s loudest themes: AI, silicon photonics, and EV power semis. The fiscal Q4 print checked all the boxes traders care about — revenue up 33%, a swing to profitability, and record bookings that translate into a roughly $100M effective backlog. Add $116.5M in cash and minimal leverage, and Aehr Test Systems now has both demand visibility and the balance sheet to chase it.

The stock’s behavior backs that up. AEHR has exploded from the high $60s to the high $90s in a matter of sessions, with intraday action showing strong support above prior resistance. That is constructive for momentum traders, but it also raises the stakes. With valuation stretched on traditional metrics and multiple analysts now modeling 160%–200% revenue growth by 2027, any stumble on orders or margins will matter.

For active traders, the edge is not in guessing where AEHR will be in five years. It is in tracking how price, volume, and news line up from here. As Tim Sykes often says, “The market rewards preparation, not prediction.” That fits Aehr Test Systems perfectly right now. The best AEHR traders will echo another principle: As Tim Bohen, lead trainer with StocksToTrade says, “Preparation is half the trade. By the time the bell rings, my decisions are nearly made.”. Study the chart, know the catalysts, respect the volatility, and stick to a trading plan. This article is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!